Potent block of Cx36 and Cx50 gap junction channels by mefloquine

Proceedings of the National Academy of Sciences of the United States of America

Volumn 101, Issue 33, 2004, Pages 12364-12369

  Cruikshank, Scott J ^b   Hopperstad, Matthew ^a   Younger, Meg ^a   Connors, Barry W ^b   Spray, David C ^a   Srinivas, Miduturu ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; CHLOROQUINE; GAP JUNCTION PROTEIN; GAP JUNCTION PROTEIN CX36; GAP JUNCTION PROTEIN CX50; MEFLOQUINE; MEPACRINE; PAMAQUINE; QUINIDINE; QUININE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIMALARIAL ACTIVITY; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG EFFECT; DRUG PROTEIN BINDING; EVOKED RESPONSE; EXCITATORY POSTSYNAPTIC POTENTIAL; GAP JUNCTION; INHIBITORY POSTSYNAPTIC POTENTIAL; INTERNEURON; MEMBRANE CHANNEL; NEOCORTEX; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION;

ANIMALS; CELL LINE; CONNEXINS; EYE PROTEINS; HIPPOCAMPUS; INTERNEURONS; MEFLOQUINE; MICE; NEOCORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SYNAPTIC TRANSMISSION; TRANSFECTION;

ANIMALIA; CINCHONA PUBESCENS;

EID: 4344601087     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0402044101     Document Type: Article

References (34)

1. Willecke, K., Eiberger, J., Degen, J., Eckardt, D., Romualdi, A., Guldenagel, M., Deutsch, U. & Sohl G. (2002) Biol. Chem. 383, 725-737.
2. White, T. W. & Paul, D. L. (1999) Annu. Rev. Physiol. 61, 283-310.
3. Guldenagel, M., Ammermuller, J., Feigenspan, A., Teubner, B., Degen, J., Sohl, G., Willecke, K. & Weiler, R. (2001) J. Neurosci. 21, 6036-6044.
4. Deans, M. R., Volgyi, B., Goodenough, D. A., Bloomfield, S. A. & Paul, D. L. (2002) Neuron 36, 703-712.
5. Deans, M. R., Gibson, J. R., Sellitto, C., Connors, B. W. & Paul, D. L. (2001) Neuron 31, 477-485.
6. Hormuzdi, S. G., Pais, I., LeBeau, F. E., Towers, S. K., Rozov, A., Buhl, E. H., Whittington, M. A. & Monyer, H. (2001) Neuron 31, 487-495.
7. Landisman, C. E., Long, M. A., Beierlein, M., Deans, M. R., Paul, D. L. & Connors, B. W. (2002) J. Neurosci. 22, 1002-1009.
8. White T. W., Goodenough, D. A. & Paul, D. L. (1998) J. Cell. Biol. 143, 815-825.
9. White, T. W. (2002) Science 295, 319-320.
10. Lin, J. H., Weigel, H., Cotrina, M. L., Liu, S., Bueno, E., Hansen, A. J., Hansen, T. W., Goldman, S. & Nedergaard, M. (1998) Nat. Neurosci. 1, 494-500.
11. Cusato, K., Bosco, A., Rozental, R., Guimaraes, C. A., Reese, B. E., Linden, R. & Spray, D. C. (2003) J. Neurosci. 23, 6413-6422.
12. Spray, D. C., Rozental, R. & Srinivas, M. (2002) Curr. Drug. Targets 3, 455-464.
13. Rouach N., Segal, M., Koulakoff, A., Giaume, C. & Avignone, E. (2003) J. Physiol. (London) 553, 729-745.
14. Srinivas, M., Hopperstad, M. G. & Spray, D. C. (2001) Proc. Natl. Acad. Sci. USA 98, 10942-10947.
15. Yatani, A., Wakamori, M., Mikala, G. & Bahinski, A. (1993) Circ. Res. 73, 351-359.
16. Snyders, J., Knoth, K. M., Roberds, S. L. & Tamkun, M. M. (1992) Mol. Pharmacol. 41, 322-330.
17. Gibson, J. R., Beierlein, M. & Connors, B. W. (1999) Nature 402, 75-79.
18. Galarreta, M. & Hestrin, S. (1999) Nature 402, 72-75.
19. Rash, J. E., Staines, W. A., Yasumura, T., Patel, D., Furman, C. S., Stelmack, G. L. & Nagy, J. I. (2000) Proc. Natl. Acad. Sci. USA 97, 7573-7538.
20. Long, M. A., Deans, M. R., Paul, D. L. & Connors, B. W. (2002) J. Neurosci. 22, 10898-10905.
21. Buhl, D. L., Harris, K. D., Hormuzdi, S. G., Monyer, H. & Buzsaki, G. (2003) J. Neurosci. 23, 1013-1018.
22. Maier, N., Guldenagel, M., Sohl, G., Siegmund, H., Willecke, K. & Draguhn, A. (2002) J. Physiol. 541, 521-528.
23. Kang, J., Chen, X. L., Wang, L. & Rampe, D. (2001) J. Pharmacol. Exp. Ther. 299, 290-296.
24. Gribble, F. M., Davis, T. M., Higham, C. E., Clark, A. & Ashcroft, F. M. (2000) Br. J. Pharmacol. 131, 756-760.
25. Maertens, C., Wei, L., Droogmans, G. & Nilius, B. (2000) J. Pharmacol. Exp. Ther. 295, 29-36.
26. Coker, S. J., Batey, A. J., Lightbown, I. D., Diaz, M. E. & Eisner, D. A. (2000) Br. J. Pharmacol. 129, 323-330.
27. Amitai, Y., Gibson, J. R., Beierlein, M., Patrick, S. L., Ho, A. M., Connors, B. W. & Golomb, D. (2002) J. Neurosci. 22, 4142-4152.
28. Kistler, J. & Bullivant, S. (1987) Invest. Ophthalmol. Visual Sci. 28, 1687-1692.
29. Jiang, J. X. & Goodenough, D. A. (1996) Proc. Natl. Acad. Sci. USA 93, 1287-1291.
30. Karbwang, J. & White, N. J. (1990) Clin. Pharmacokinet. 19, 264-279.
31. Foley, M. & Tilley, L. (1998) Pharmacol. Ther. 79, 55-87.
32. Palmer, K. J., Holliday, S. M. & Brogden, R. N. (1993) Drugs 52, 430-475.
33. De Zeeuw, C. I., Chorev, E., Devor, A., Manor, Y., Van Der Giessen, R. S., De Jeu, M. T., Hoogenraad, C. C., Bijman, J., Ruigrok, T. J., French, P., et al. (2003) J. Neurosci. 23, 4700-4711.
34. Iacobas, D. A., Urban, M., Iacobas, S., Scemes, E. & Spray, D. C. (2003) Physiol. Genom. 15, 177-190.